Clinical Study
Clinicopathological Characteristics and Her-2/neu Status in Chinese Patients with Uterine Papillary Serous Carcinoma
Table 3
Univariate analysis of Her-2/neu IHC status and clinicopathological factors with overall survival.
| | No. of patients | No. of Deaths | Survival Rate (%) | value | | 1-year | 3-years | 5-years |
| | 36 | 17 | 73.1 | 51.9 | 43.9 | | | Her-2/neu by IHC | | | | | | .0023 | | āPositive | 13 | 11 | 60 | 25.7 | 12.9 | | | āNegative | 23 | 6 | 81 | 68.6 | 68.6 | | | Stage | | | | | | .0006 | | āIII | 14 | 3 | 92.6 | 84.5 | 60.4 | | | āIIIIV | 22 | 14 | 60 | 26.7 | 16 | | | Myometrial invasion | | | | | | .0138 | | ā1/2 | 15 | 4 | 85.7 | 77.6 | 55.4 | | | āā©¾1/2 | 21 | 13 | 64.1 | 33.1 | 19.9 | | | Histology | | | | | | .948 | | āPure | 21 | 10 | 74.4 | 50.6 | 30.3 | | | āMixed | 15 | 7 | 71.4 | 54 | 36 | | | LVSI | | | | | | .4884 | | āPresent | 20 | 10 | 63.2 | 51.1 | 30.7 | | | āAbsent | 16 | 7 | 86.2 | 52.8 | 37.7 | | | Grade | | | | | | .8689 | | āII | 6 | 3 | 75 | 50 | 50 | | | āIII | 30 | 14 | 68.4 | 51.8 | 41.5 | |
|
|
